CEL-SCI Expands Its Phase III Head and Neck Cancer Trial into Sri Lanka

15th nation to join world’s largest Head and Neck cancer Phase III trial July 17, 2014 CEL-SCI Corporation today announced that Sri Lanka’s Ministry of Health has cleared the Company to commence patient enrollment for its Phase III Head and Neck Cancer clinical trial of its investigational cancer immunotherapy treatment Multikine* (Leukocyte Interleukin, Injection) in Sri Lanka. This follows similar clearance to conduct the …